Document is current
Any future updates will be listed below
-
Authors
Matsuda, Satoru
Takeuchi, Hiroya
Kato, Ken
Kitagawa, Yuko
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 7 October 2024
First Online: 28 October 2024
Disclosures
: Ken Kato reports funding to the institution from Merck Sharp & Dohme Corp, Ono Pharmaceuticals, Bristol Myers Squibb, Beigene, Shionogi, Merck Biopharma, Oncolys BioPharma, Daiichi Sankyo, Novartis, Taiho Pharmaceutical, Janssen, AstraZeneca, and Chugai. The remaining authors have no conflicts of interest.
